Brentuximab extravasation injury in a patient with mycosis fungoides with large cell transformation
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15751
Abstract: non-Hodgkin lymphomas extracutaneous the of and are indo-lent. 1,2 CD30 positivity may suggest the potential for large cell transformation and progression. 3 Brentuximab vedotin (BV) is an anti-CD30 antibody-drug conjugate newly approved to treat CD30… read more here.
Keywords: large cell; cell transformation; brentuximab extravasation;